Irving Investors
Irving Investors is a private equity firm that offers investment services to healthcare, real estate, and automobile sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Irving Investors Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Irving Investors is a private equity firm that offers investment services to healthcare, real estate, and automobile sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2018 | Rumble | Venture Round | - |
| 1/2022 | Arctic Wolf | Secondary Market | - |
| 1/2022 | DNA Script | Series C | 0 |
| 1/2022 | Metagenomi | Series B | 0 |
| 9/2019 | Rebel Foods | Series D | 0 |
| 5/2019 | Pearl | Series A | 11M |
| 4/2013 | Instacart | Series A | 8.5M |
| 5/2019 | Foghorn Therapeutics | Venture Round | 61M |
| 12/2021 | Bombas | Secondary Market | - |
| 4/2019 | PAX Labs | Venture Round | 0 |
| 1/2022 | Leap Services | Series B | 0 |
| 11/2020 | Imago BioSciences | Series C | 80M |
| 7/2019 | Rebel Foods | Series D | 125M |
| 4/2021 | LUMICKS | Series D | 0 |
| 11/2020 | Prometheus Biosciences | Equity | 130M |
| 7/2021 | Cybereason | Series F | 0 |
| 8/2019 | ThredUp | Series F | 175M |
| 6/2020 | Goldfinch Biopharma | Series B | 100M |
| 2/2017 | Goat Group | Series B | 25M |
| 12/2019 | Rubrik | Secondary Market | - |
| 9/2022 | Klaviyo | Secondary Market | - |
| 2/2018 | Goat Group | Series C | 60M |
| 1/2018 | Anaplan | Secondary Market | - |
| 7/2021 | Genomatica | Series C | 0 |
| 8/2016 | Goat Group | Series A | 5M |
| 8/2017 | Bombas | Debt Financing | - |
| 2/2021 | Nuvation Bio | Post-IPO Equity | 502M |
| 8/2021 | InterVenn | Series C | 0 |
| 5/2021 | BioTheryX | Series E | 92M |
| 3/2021 | EGenesis | Series C | 0 |
| 2/2020 | SentinelOne | Series E | 0 |
| 7/2020 | Praxis Precision Medicines | Series C | 0 |
| 8/2019 | ORIC Pharmaceuticals | Series D | 0 |
| 12/2022 | Snyk | Series G | 0 |
| 11/2021 | Shoreline Biosciences | Series B | 0 |
| 3/2021 | Crossover Health | Series D | 0 |
| 3/2007 | Lyft | Secondary Market | - |
| 10/2018 | Dixie Brands | Series C | 25M |
| 1/2022 | Checkr | Secondary Market | - |
| 2/2021 | Model Medicines | Seed Round | 4.1M |
| 1/2021 | NexImmune | Convertible Note | 50M |
| 3/2021 | Absci | Venture Round | 0 |
| 1/2022 | Leap Services | Series B | 0 |
| 1/2022 | Metagenomi | Series B | 0 |
| 1/2022 | Checkr | Secondary Market | - |
| 1/2022 | Arctic Wolf | Secondary Market | - |
| 1/2022 | DNA Script | Series C | 0 |
| 12/2021 | Bombas | Secondary Market | - |
| 11/2021 | Shoreline Biosciences | Series B | 0 |
| 8/2021 | InterVenn | Series C | 0 |
| 7/2021 | Genomatica | Series C | 0 |
| 7/2021 | Cybereason | Series F | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
